Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adults or adolescents at least 16 years of age;
HIV-1 infection;
clinically stable, treatment-experienced;
evidence of HIV-1 replication despite ongoing antiretroviral therapy;
CD4 + count greater than 50 cells/mm3.
You may not be if
previous use of Fuzeon and/or T-1249;
active, untreated opportunistic infection;
inability to self-inject, unless a reliable caregiver is available to inject.
Clareo Health | QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
